Waystar (WAY) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Achieved Q3 2024 revenue of $240.1 million, up 22% year-over-year, with net income of $5.4 million and adjusted EBITDA of $96.7 million at a 40% margin.
Net revenue retention was 109%, with 1,173 clients generating over $100,000 in trailing twelve-month revenue, up 14% year-over-year.
Growth driven by client retention, cross-selling, new client acquisitions, platform innovation, and rapid onboarding after a competitor's cyber event.
Paid down over $1 billion in debt year-to-date, reducing annual interest expense by more than $100 million and improving credit ratings.
Completed an IPO in June 2024, raising over $1 billion in net proceeds.
Financial highlights
Q3 2024 revenue was $240.1 million, up 21.7%–22% year-over-year; adjusted EBITDA was $96.7 million, with a 40% margin.
Net income for Q3 2024 was $5.4 million, compared to a net loss in the prior year; non-GAAP net income was $25.3 million.
Unlevered free cash flow for Q3 2024 was $89 million, with a 92% EBITDA to free cash flow conversion.
For the nine months ended September 30, 2024, revenue was $699.4 million, up 19.7% year-over-year.
Cash and cash equivalents at September 30, 2024 were $127.1 million.
Outlook and guidance
Full-year 2024 revenue guidance is $926–$934 million, representing 17–18% growth over 2023.
Adjusted EBITDA guidance for 2024 is $374–$378 million, with a 40% margin.
Non-GAAP net income expected to be $47–$50 million, with diluted non-GAAP EPS of $0.30–$0.32.
Preliminary 2025 revenue expected to approach $1 billion, with high single-digit as-reported growth.
Management expects continued growth in subscription and volume-based revenues, supported by client expansion and adoption of additional solutions.
Latest events from Waystar
- Record FY2025 growth, 43% Q4 EBITDA margin, and strong 2026 outlook with AI momentum.WAY
Q4 202517 Feb 2026 - AI-powered automation streamlines healthcare payments, boosting efficiency and financial outcomes.WAY
Waystar True North Client Conference3 Feb 2026 - Q2 revenue up 20% to $234.5M, 40% EBITDA margin, and improved leverage ratios.WAY
Q2 20242 Feb 2026 - Modern, AI-powered platform drives growth, efficiency, and client wins amid rising cybersecurity focus.WAY
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - AI-driven automation and data integration fuel growth, efficiency, and client satisfaction.WAY
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026 - Cloud-based healthcare payment software drives growth, efficiency, and resilience in a shifting market.WAY
7th Annual Evercore ISI HealthCONx Healthcare Conference11 Jan 2026 - Strong Q3 growth, durable revenue, and 40% EBITDA margins drive market share gains.WAY
Barclays 22nd Annual Global Technology Conference 202411 Jan 2026 - AI-driven healthcare payment automation accelerates growth, efficiency, and industry leadership.WAY
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - 2024 revenue up 19% with strong margins; 2025 guidance targets 7–10% growth and ongoing innovation.WAY
Q4 20246 Jan 2026